Sort
51,570 grants matching “autoimmune disease”
Cellular and Genetic Basis of Systemic Lupus
$579,832Shu Man Fu · University Of Virginia · R01 · FY2016 · AR
Molecular and clinical predictors of relapse in ANCA-associated vasculitis
$579,765Rennie Rhee · University Of Pennsylvania · R01 · FY2024 · AR
New Costimulatory Pathways: Functions and Interactions
$579,668Brigham And Women'S Hospital · P01 · FY2003 · AI
Development Of Drugs Acting At Adenosine Receptors
$579,661Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Engineering and Analysis of T cell CD3 and IL2R Signals
$579,644Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2007 · AI
Project 1: Transgenic TCR-mediated tumor therapy
$579,552Philip D Greenberg · University Of Washington · P01 · FY2023 · CA
Studies of Thyroid Function in Health and Disease
$579,533Monica Skarulis · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Sex and gender differences in lupus - intersection between immunometabolism, epigenetic remodeling and cardiac involvement
$579,523Caroline Jefferies · Cedars-Sinai Medical Center · R01 · FY2021 · AI
IL-35 suppression of endothelial cell activation and atherosclerosis
$579,450Xiao-Feng Yang · Temple Univ Of The Commonwealth · R01 · FY2018 · HL
Uncovering pathogenic anti-bacterial defense mechanisms to identify novel targets for prevention of T1D
$579,412Nora E Sarvetnick · University Of Nebraska Medical Center · U01 · FY2021 · AI
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
$579,321Brian T Campfield · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
$579,321Brian T Campfield · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
$579,321Brian T Campfield · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL
Chromatin architecture as a regulator of dendritic cell function
$579,256Boris Reizis · New York University School Of Medicine · R01 · FY2022 · AI
Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses
$579,236Jing Jin · Northwestern University At Chicago · R01 · FY2025 · EB
Treatment of lupus nephritis with nanoparticles that selectively target kidney glomeruli
$579,208Ruisheng Liu · University Of South Florida · R01 · FY2023 · DK
Development of a novel method for inhibiting diabetic retinopathy
$579,202David R Clemmons · Cmp Tarnhelm Partners, Llc · R42 · FY2016 · EY
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
$579,177Jung-Hyun Park · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
$579,176Pepper J Schedin · Oregon Health & Science University · R01 · FY2016 · CA
Career Development and Outreach in Musculoskeletal, Autoimmune and Skin Disease
$578,932Mario Cerritelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIJ · FY2010 · AR
Polyamines and Hypusine in Type 1 Diabetes Pathogenesis
$578,915Raghavendra G Mirmira · University Of Chicago · R01 · FY2025 · DK
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium
$578,905Jill P Buyon · New York University School Of Medicine · UH2 · FY2016 · AR
TCR signaling control of thymic Treg selection and immune homeostasis
$578,865Eric S Huseby · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI
Mechanisms of Allergen-induced Type 2 Immunity
$578,847Hirohito Kita · Mayo Clinic Arizona · R37 · FY2024 · AI
Enzymes and enzyme complexes in RNA metabolism
$578,843Eckhard Jankowsky · Case Western Reserve University · R35 · FY2020 · GM